LeValley Paige J, Parsons Amanda L, Sutherland Bryan P, Kiick Kristi L, Oakey John S, Kloxin April M
Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716, USA.
Chemical Engineering, University of Wyoming, Laramie, WY 82071, USA.
Pharmaceutics. 2022 May 15;14(5):1062. doi: 10.3390/pharmaceutics14051062.
Protein therapeutics have become increasingly popular for the treatment of a variety of diseases owing to their specificity to targets of interest. However, challenges associated with them have limited their use for a range of ailments, including the limited options available for local controlled delivery. To address this challenge, degradable hydrogel microparticles, or microgels, loaded with model biocargoes were created with tunable release profiles or triggered burst release using chemistries responsive to endogenous or exogeneous stimuli, respectively. Specifically, microfluidic flow-focusing was utilized to form homogenous microgels with different spontaneous click chemistries that afforded degradation either in response to redox environments for sustained cargo release or light for on-demand cargo release. The resulting microgels were an appropriate size to remain localized within tissues upon injection and were easily passed through a needle relevant for injection, providing means for localized delivery. Release of a model biopolymer was observed over the course of several weeks for redox-responsive formulations or triggered for immediate release from the light-responsive formulation. Overall, we demonstrate the ability of microgels to be formulated with different materials chemistries to achieve various therapeutic release modalities, providing new tools for creation of more complex protein release profiles to improve therapeutic regimens.
由于蛋白质疗法对目标靶点具有特异性,因此在治疗多种疾病方面越来越受欢迎。然而,与之相关的挑战限制了它们在一系列疾病中的应用,包括局部控释的选择有限。为了应对这一挑战,制备了负载模型生物药物的可降解水凝胶微粒(即微凝胶),其具有可调的释放曲线,或分别使用对内源性或外源性刺激有响应的化学方法触发突发释放。具体而言,利用微流控流动聚焦技术形成具有不同自发点击化学性质的均匀微凝胶,这些微凝胶可根据氧化还原环境实现降解以持续释放药物,或根据光照实现按需释放药物。所得微凝胶尺寸合适,注射后可保留在组织内,并且很容易通过与注射相关的针头,为局部给药提供了途径。对于氧化还原响应性制剂,在数周内观察到模型生物聚合物的释放,而光响应性制剂则触发了立即释放。总体而言,我们证明了微凝胶能够用不同的材料化学方法进行制备,以实现各种治疗性释放模式,为创建更复杂的蛋白质释放曲线以改善治疗方案提供了新工具。